Male Breast Cancer Completed Phase 2 Trials for Becatecarin (DB06362)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00005817Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast CancerTreatment